|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Product revenue | |||||
| Cost of product revenue | |||||
| Product gross profit | |||||
| Collaborations revenue | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Fair value change in warrant liability | |||||
| Financing costs | |||||
| Other income, net | |||||
| Loss before income taxes | |||||
| Net loss | |||||
| Net loss per share: | |||||
| Basic (in Dollars per share) | |||||
| Diluted (in Dollars per share) | |||||
| Number of shares used in per share calculations: | |||||
| Basic (in Shares) | |||||
| Diluted (in Shares) | |||||
Loading...